DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer detection, is announcing the appointment...
AbbVie and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing therapies using a novel blood-brain barrier...
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing...
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced the launch of its EXpressCTSM (Expression Signatures Through Circulating Tumor Signals) liquid biopsy platform...
Movemedical, the enterprise software platform for medical device inventory management, is pleased to announce a strategic investment partnership with Resurgens Technology Partners. This investment...
